|
Adamis Pharmaceuticals (formerly Cellegy Pharmaceuticals) adamantly develops and markets specialty prescription drugs for respiratory ailments, allergies, viral infections, and other medical conditions. Subsidiary Adamis Labs develops and markets allergy, respiratory, and pediatric prescription medicines to physicians in the US. Adamis Viral Therapies is developing vaccine technologies for ailments such as influenza and hepatitis. The company is also developing Savvy, a contraceptive gel. After selling several drug programs and considering strategic alternatives, the company merged with a privately held specialty drug maker (Adamis Pharmaceuticals) and took on the Adamis name in 2009.
|
| | | Contact Information | |
Address: |
2658 Del Mar Heights Rd., No. 555
Del Mar, CA 92014
| | Phone: | 858-401-3984 | | Fax: | |
|
| Financial
Highlights | | Fiscal Year End: | March | | Revenue (2008): | 0.00 M | | Employees (2008): | 14 | | Employee Growth (1 yr): | 366.70% |
|
|
Key People
| | • |
President , CEO, and Director:
Dennis J. Carlo
| | • |
CFO and Secretary:
Robert O. Hopkins
| | • |
VP Business Development and Investor Relations, and Director:
David J. Marguglio
|
|
|
